ATRS has gained $0.13 from the previous closing price of $2.75 on volume of 318,338 shares. The company has a market capitalization of $664.98 Million. Antares Pharma, Inc. Common Stock, also called Antares Pharma, is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Antares Pharma, Inc. (NASDAQ:ATRS) concluded the trading at $3.99 on Thursday, Dec 17 with a rise of 2.05% from its closing price on previous day. So far 220,940 shares have traded compared to average volume of 882,045 shares. Discover historical prices for ATRS stock on Yahoo Finance. Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference View today's stock price, news and analysis for Antares Pharma Inc. (ATRS). Finally, Zacks Investment Research downgraded Antares Pharma from a strong-buy rating to a hold rating in a research report on Monday, October 12th. Key Financials. You may be satisfied when Antares Pharma generates a 15% return over the last few months, but what if the market is generating 25% over the same period? Click here now. Over the past year the S&P 500 is higher by 20.50% while ATRS is lower by -8.28%. QPP Quindell FTSE. View daily, weekly or monthly format back to when Antares Pharma, Inc. stock was issued. Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Antares Pharma stock price gained 2.05% on the last trading day (Thursday, 17th Dec 2020), rising from $3.91 to $3.99. Antares Pharma Stock - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Nov 2020. The stock price has decreased by -30.71% in the last 52 weeks. BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a hold rating to a buy rating in a research report sent to investors on Thursday, BidAskClub reports. The company has a market capitalization of $508.24 Million. Their average twelve-month price target is $5.63, predicting that the stock has a possible upside of 63.99%. GlobeNewswire. Antares Pharma, Inc. (NASDAQ:ATRS) Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.87 on the last trading session with an decrease of -3.01%, whereas, it previously closed at $3.99. Read More Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. ATRS has been the topic of several other research reports. Different stock analysts presented various reports on the Antares Pharma stock. ET by Tomi Kilgore. According to a report by H.C Wainwright, ATRS shares were a “Buy.” The brokerage firm predicted a $3.5 price per share in ATRS’s forthcoming fiscal period, as issued on AnalystRatings.com. ANTARES PHARMA, INC. : Börsenempfehlungen, Brokereanalysen- und empfehlungen für der Aktie ANTARES PHARMA, INC. | ATRS | Nasdaq Zacks Investment Research lowered Antares Pharma from a strong-buy rating to a hold rating in a research report on […] UKX FTSE 100 LSE. Stock analysis for Antares Pharma Inc (AIS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Antares Pharma stock price ended on $3.99 on Thursday after gaining 2.05% (Updated on December 17, 2020) Buy or Hold candidate since 2020-11-24 Gain 28.71% PDF . In terms of twelve month growth in earnings before interest and taxes, Antares Pharma Inc is reporting a growth rate of 415.74%; that's higher than 96.51% of US stocks. Register now to create your own custom streaming stock watchlist. Antares Pharma (NASDAQ:ATRS) Intraday Stock Chart Saturday 19 December 2020 Your Recent History LSE. A look at the daily price movement … Top institutional investors include BlackRock Inc. (6.92%), State Street Corp (2.51%), Stonepine Capital Management LLC (0.72%), Charles Schwab Investment Management Inc. (0.61%), JPMorgan Chase & Co. (0.46%) and AQR Capital Management LLC (0.44%). Antares Pharma, Inc. Common Stock (ATRS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Mar-06-19 07:00AM : Antares Pharma to Present at the Cowen and Company 39th Annual Healthcare Conference . Market Cap 556.68M: Dividend Yield n/a: Revenue (ttm) $143.31M: Net Income (ttm) $9.51M: PE Ratio 58.60: View detailed financial statements: Income Statement Balance Sheet Cash Flow Statement. Dive deeper with interactive charts and top stories of ANTARES PHARMA, INC.. Antares Pharma Inc (ATRS) stock has gained 4.73% while the S&P 500 is lower by -0.17% as of 10:42 AM on Monday, Aug 31. Antares Pharma Inc. (NASDAQ:ATRS) went down by -0.87% from its latest closing price compared to the recent 1-year high of $4.90. These institutions hold a total of 92,062,734 shares. The high price target for ATRS is $7.00 and the low price target for ATRS is $4.50. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.39 and has seen 1,428,722 shares traded in the last trading session. The company was … 4 Wall Street analysts have issued ratings and price targets for Antares Pharma in the last 12 months. Antares Pharma Inc (ATRS) stock is trading at $2.99 as of 10:50 AM on Monday, Oct 5, a gain of $0.11, or 3.88% from the previous closing price of $2.88. Feb-28-19 12:31PM : Antares Pharma Inc (ATRS) … Antares Pharma (NASDAQ:ATRS), GreenSky ... Antares has traded at penny-stock levels for more than 20 years, so this growth could serve as a long-awaited catalyst. AMAG's Stock Down as Pregnancy Drug Fails in PROLONG Study. For now, the stock … To evaluate Antares Pharma Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. Antares Pharma's stock plunges 40% premarket toward 8-mo. Volume today is low. Mar-04-19 07:00AM : Antares Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella. Antares Pharma Inc. (NASDAQ:ATRS) went up by 2.05% from its latest closing price compared to the recent 1-year high of $4.90. Get the hottest stocks to trade every day before the market opens 100% free. Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference […] The company, currently valued at $650.02 Million, closed the last trade at $3.9 per share which meant it gained $0.17 on the day or 4.42% during that session. If you had put $1,000 dollars into Antares Pharma stock , it would be worth today. The beta is 1.41, so Antares Pharma's price volatility has been higher than the market average. Zacks. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. Get the hottest stocks to trade every day before the market opens 100% free. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Antares Pharma, Inc. (NASDAQ:ATRS) Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.14 on the last trading session with an increase of 0.64%, whereas, it previously closed at $3.12. GlobeNewswire. low after FDA letter late Thursday.
Maximum Number Of Columns In Mysql Table,
Edisto Beach Shelling,
Chemical Measuring Stick,
32 Inch Elsa Doll,
Port Arthur, Texas Population 2020,